San Francisco-based Plenful, a workflow-automation platform for pharmacy and healthcare operations, introduced it secured $17 million in Sequence A funding lower than a yr after launching with $9 million in funding.
TQ Ventures led the spherical, with participation from Mitchell Rales (cofounder and chairman of Danaher), Susa Ventures and present traders.
WHAT IT DOES
Plenful provides pharmacy technicians a no-code AI-enabled automation software for handbook and administrative workflow that features assist with doc knowledge entry for pharmacy income cycle, referral orders, auditing and financial savings identification.
The corporate will use the funds to scale advertising, gross sales and product improvement.
“We’re dedicated to reworking pharmacy and healthcare operations by addressing the handbook and administrative work that burdens the system, exacerbated by a big decline in graduating pharmacists, by revolutionary AI automation options,” Pleasure Liu, founder and CEO of Plenful, informed MobiHealthNews in an e mail.
“By streamlining operations and assuaging labor shortages, we empower healthcare groups to prioritize affected person care. Plenful is devoted to enhancing pharmacy care supply and shaping a extra environment friendly future for healthcare.”
MARKET SNAPSHOT
One other firm that secured funding this week for its workflow automation platform is SamaCare.
The corporate helps suppliers get hold of prior authorization for specialty drug drugs, examine enrollment, and confirm advantages. It additionally makes use of knowledge analytics to offer pharmaceutical firms with data on enhancing remedy entry.
SamaCare additionally secured $17 million in funding.
